163 related articles for article (PubMed ID: 3579075)
1. Endoscopic surveillance for patients with Barrett esophagus: does the cancer risk justify the practice?
Spechler SJ
Ann Intern Med; 1987 Jun; 106(6):902-4. PubMed ID: 3579075
[No Abstract] [Full Text] [Related]
2. Endoscopic surveillance in Barrett's oesophagus.
Ryan J
Gut; 2003 Apr; 52(4):612; author reply 612. PubMed ID: 12631684
[No Abstract] [Full Text] [Related]
3. Goblet Cell Ratio in Combination with Differentiation and Stem Cell Markers in Barrett Esophagus Allow Distinction of Patients with and without Esophageal Adenocarcinoma.
Schellnegger R; Quante A; Rospleszcz S; Schernhammer M; Höhl B; Tobiasch M; Pastula A; Brandtner A; Abrams JA; Strauch K; Schmid RM; Vieth M; Wang TC; Quante M
Cancer Prev Res (Phila); 2017 Jan; 10(1):55-66. PubMed ID: 27807078
[TBL] [Abstract][Full Text] [Related]
4. Overutilization of endoscopic surveillance in nondysplastic Barrett's: too much of a good thing?
Klibansky DA; Gordon SR; Gardner TB
Gastroenterology; 2012 Jun; 142(7):1614-6. PubMed ID: 22537646
[No Abstract] [Full Text] [Related]
5. Barrett's esophagus surveillance: When, how often, does it work?
Katona BW; Falk GW
Gastrointest Endosc Clin N Am; 2011 Jan; 21(1):9-24. PubMed ID: 21112494
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and recognition of early esophageal neoplasia.
Herszényi L; Pregun I; Tulassay Z
Dig Dis; 2009; 27(1):24-30. PubMed ID: 19439957
[TBL] [Abstract][Full Text] [Related]
7. Risk of malignant progression in patients with Barrett's oesophagus: a Dutch nationwide cohort study.
de Jonge PJ; van Blankenstein M; Looman CW; Casparie MK; Meijer GA; Kuipers EJ
Gut; 2010 Aug; 59(8):1030-6. PubMed ID: 20639249
[TBL] [Abstract][Full Text] [Related]
8. [No grounds for Barrett hysteria. Current monitoring strategies are adequately reliable].
Schilling D; Riemann JF
MMW Fortschr Med; 2002 Jul; 144(27-28):40-1. PubMed ID: 12198878
[No Abstract] [Full Text] [Related]
9. Low-grade dysplasia in Barrett's esophagus.
Odze RD; Goldblum JR
Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1419-20; author reply 1420. PubMed ID: 17110303
[No Abstract] [Full Text] [Related]
10. Endotherapies for Barrett esophagus.
Bennett RD; Velanovich V
Minerva Chir; 2016 Oct; 71(5):300-10. PubMed ID: 27391221
[TBL] [Abstract][Full Text] [Related]
11. Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus.
Whitson MJ; Falk GW
Gastroenterol Clin North Am; 2015 Jun; 44(2):299-315. PubMed ID: 26021196
[TBL] [Abstract][Full Text] [Related]
12. To perform a biopsy or not to perform a biopsy? Does confocal endomicroscopy provide the answer for surveillance in Barrett's esophagus?
Hwang JH
Gastrointest Endosc; 2009 Oct; 70(4):655-7. PubMed ID: 19788981
[No Abstract] [Full Text] [Related]
13. [Barrett esophagus--esophageal carcinoma: diagnosis].
Schwacha H
Praxis (Bern 1994); 2002 May; 91(20):877-80. PubMed ID: 12071089
[TBL] [Abstract][Full Text] [Related]
14. The cost of surveillance for adenocarcinoma complicating Barrett's esophagus.
Achkar E; Carey W
Am J Gastroenterol; 1988 Mar; 83(3):291-4. PubMed ID: 3125739
[TBL] [Abstract][Full Text] [Related]
15. Endoscopic diagnosis of subsquamous invasion of adenocarcinoma in short-segment Barrett's esophagus.
Takahashi A; Oyama T
Dig Endosc; 2017 Apr; 29 Suppl 2():38-39. PubMed ID: 28425664
[No Abstract] [Full Text] [Related]
16. Management of Barrett's esophagus: cases and questions.
Bresalier R
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S2-5. PubMed ID: 16399421
[TBL] [Abstract][Full Text] [Related]
17. Barrett's esophagus and adenocarcinoma risk: the experience of the North-Eastern Italian Registry (EBRA).
Rugge M; Zaninotto G; Parente P; Zanatta L; Cavallin F; Germanà B; Macrì E; Galliani E; Iuzzolino P; Ferrara F; Marin R; Nisi E; Iaderosa G; Deboni M; Bellumat A; Valiante F; Florea G; Della Libera D; Benini M; Bortesi L; Meggio A; Zorzi MG; Depretis G; Miori G; Morelli L; Cataudella G; d'Amore ES; Franceschetti I; Bozzola L; Paternello E; Antonini C; Di Mario F; Dal Bò N; Furlanetto A; Norberto L; Polese L; Iommarini S; Farinati F; Battaglia G; Diamantis G; Realdon S; Guido E; Mastropaolo G; Canova D; Guerini A; Franceschi M; Zirillo M
Ann Surg; 2012 Nov; 256(5):788-94; discussion 794-5. PubMed ID: 23095623
[TBL] [Abstract][Full Text] [Related]
18. Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia.
Anandasabapathy S; Jhamb J; Davila M; Wei C; Morris J; Bresalier R
Cancer; 2007 Feb; 109(4):668-74. PubMed ID: 17211862
[TBL] [Abstract][Full Text] [Related]
19. Barrett esophagus: risk factors for progression to dysplasia and adenocarcinoma.
Oberg S; Wenner J; Johansson J; Walther B; Willén R
Ann Surg; 2005 Jul; 242(1):49-54. PubMed ID: 15973101
[TBL] [Abstract][Full Text] [Related]
20. [Early esophageal carcinoma: diagnosis and endoscopic therapy].
Ell C
Z Gastroenterol; 2002 Dec; 40 Suppl 2():12-4. PubMed ID: 12466997
[No Abstract] [Full Text] [Related]
[Next] [New Search]
